Reuters logo
BRIEF-Protalix Biotherapeutics reports Q1 loss per share $0.07 excluding items
May 10, 2017 / 11:44 AM / in 5 months

BRIEF-Protalix Biotherapeutics reports Q1 loss per share $0.07 excluding items

May 10 (Reuters) - Protalix Biotherapeutics Inc:

* Protalix Biotherapeutics reports 2017 first quarter results and provides corporate update

* Q1 revenue $2.9 million versus $679,000

* Protalix Biotherapeutics Inc qtrly research and development expenses were $4.6 million, compared to $6.0 million for same period in 2016

* Protalix Biotherapeutics - on March 31, 2017 Co had $48.0 million of cash and cash equivalents, which is currently projected to fund operations into 2019

* Q1 loss per share $0.07 excluding items

* Q1 earnings per share view $-0.09, revenue view $2.6 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below